These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27808011)

  • 1. Bronchodilator effects of ipratropium bromide and albuterol sulfate among subjects with tetraplegia.
    Schilero GJ; Hobson JC; Singh K; Spungen AM; Bauman WA; Radulovic M
    J Spinal Cord Med; 2018 Jan; 41(1):42-47. PubMed ID: 27808011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airflow obstruction and reversibility in spinal cord injury: evidence for functional sympathetic innervation.
    Radulovic M; Schilero GJ; Wecht JM; Weir JP; Spungen AM; Bauman WA; Lesser M
    Arch Phys Med Rehabil; 2008 Dec; 89(12):2349-53. PubMed ID: 19061747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of airway caliber and bronchodilator responsiveness in subjects with spinal cord injury.
    Schilero GJ; Grimm DR; Bauman WA; Lenner R; Lesser M
    Chest; 2005 Jan; 127(1):149-55. PubMed ID: 15653976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilatory effects of ipratropium bromide in patients with tetraplegia.
    Almenoff PL; Alexander LR; Spungen AM; Lesser MD; Bauman WA
    Paraplegia; 1995 May; 33(5):274-7. PubMed ID: 7630654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
    Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
    Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
    Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
    Craven D; Kercsmar CM; Myers TR; O'riordan MA; Golonka G; Moore S
    J Pediatr; 2001 Jan; 138(1):51-58. PubMed ID: 11148512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI.
    Sutherland ER; Brazinsky S; Feldman G; McGinty J; Tomlinson L; Denis-Mize K
    Curr Med Res Opin; 2009 Mar; 25(3):653-61. PubMed ID: 19232039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD.
    Norris V; Ambery C
    Pulm Pharmacol Ther; 2013 Oct; 26(5):574-80. PubMed ID: 23524017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
    Colice GL
    Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O; Manier G; Castaing Y
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group.
    FitzGerald JM; Grunfeld A; Pare PD; Levy RD; Newhouse MT; Hodder R; Chapman KR
    Chest; 1997 Feb; 111(2):311-5. PubMed ID: 9041974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility.
    Bleecker ER; Emmett A; Crater G; Knobil K; Kalberg C
    Pulm Pharmacol Ther; 2008 Aug; 21(4):682-8. PubMed ID: 18541448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
    Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of age and bronchial obstruction on the elderly bronchodilation response].
    Loureiro CC
    Acta Med Port; 2011; 24(6):905-12. PubMed ID: 22713184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma.
    Houghton CM; Woodcock AA; Singh D
    Br J Clin Pharmacol; 2005 Feb; 59(2):152-9. PubMed ID: 15676036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
    Browne GJ; Trieu L; Van Asperen P
    Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma.
    Groggins RC; Milner AD; Stokes GM
    Arch Dis Child; 1981 May; 56(5):342-4. PubMed ID: 6455096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.